Immunic, Inc. (IMUX)
16.50
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
16.50
0.00 (0.00%)
After-Hours: 20:00
Immunic Total Assets (Quarterly) : 159.17M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 159.17M |
| March 31, 2026 | 189.74M |
| December 31, 2025 | 24.05M |
| September 30, 2025 | 40.70M |
| June 30, 2025 | 61.43M |
| March 31, 2025 | 20.52M |
| December 31, 2024 | 40.87M |
| September 30, 2024 | 64.76M |
| June 30, 2024 | 86.49M |
| March 31, 2024 | 104.16M |
| December 31, 2023 | 54.30M |
| September 30, 2023 | 66.98M |
| June 30, 2023 | 88.74M |
| March 31, 2023 | 108.87M |
| December 31, 2022 | 127.75M |
| September 30, 2022 | 121.08M |
| June 30, 2022 | 138.66M |
| March 31, 2022 | 149.92M |
| December 31, 2021 | 139.10M |
| September 30, 2021 | 156.76M |
| June 30, 2021 | 136.06M |
| March 31, 2021 | 154.72M |
| December 31, 2020 | 167.86M |
| September 30, 2020 | 171.64M |
| June 30, 2020 | 87.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 57.29M |
| December 31, 2019 | 65.96M |
| September 30, 2019 | 67.60M |
| June 30, 2019 | 72.57M |
| March 31, 2019 | 10.48M |
| December 31, 2018 | 13.37M |
| September 30, 2018 | 19.99M |
| June 30, 2018 | 34.80M |
| March 31, 2018 | 47.01M |
| December 31, 2017 | 60.38M |
| September 30, 2017 | 70.36M |
| June 30, 2017 | 80.68M |
| March 31, 2017 | 90.95M |
| December 31, 2016 | 64.03M |
| September 30, 2016 | 72.47M |
| June 30, 2016 | 78.63M |
| March 31, 2016 | 82.92M |
| December 31, 2015 | 89.08M |
| September 30, 2015 | 66.94M |
| June 30, 2015 | 79.87M |
| March 31, 2015 | 94.92M |
| December 31, 2014 | 108.08M |
| September 30, 2014 | 85.83M |
| June 30, 2014 | 97.02M |
| March 31, 2014 | 55.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Sionna Therapeutics, Inc. | 283.25M |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.59M |
| Shareholders Equity (Quarterly) | 127.58M |
| Debt to Equity Ratio | 0.0044 |
| Current Ratio | 5.049 |
| Net Debt Paydown Yield | 0.04% |